Core Viewpoint - Hagens Berman is investigating Trex Company, Inc. for potential violations of U.S. securities laws, focusing on undisclosed sales practices and inflated sales figures through overstocking its "pro channel" partners while misleading investors about its inventory management strategy [1]. Group 1: Investigation Details - The investigation centers on whether Trex concealed excess inventory buildup at distributors [4]. - Trex's sales growth forecast for 2025 was revised down from +7% to 0% due to disappointing financial results [4][7]. - The company reported Q3 2025 net sales of $285 million, which was 5% below its guidance and represented a sequential decline of approximately 26% [6]. Group 2: Market Impact - Trex's stock experienced a 31% drop on November 5, 2025, resulting in a market cap loss of around $1.5 billion [4]. - The company's announcement of a "muted" fourth quarter and the expectation that pro channel partners would lower their inventories contributed to the stock's decline [7]. Group 3: Management Statements - In August 2025, Trex management claimed that their "level-loading" production strategy would reduce inventory volatility and enhance operational efficiency [5]. - The investigation seeks to determine if Trex was aware of softening demand but continued to push products to meet short-term targets [8]. Group 4: Additional Information - The investigation is open to whistleblowers with non-public information regarding Trex, who may receive rewards under the SEC Whistleblower program [11].

Core Viewpoint - A securities class action lawsuit has been filed against Ardent Health, Inc. following its poor Q3 2025 financial results, alleging misleading statements regarding revenue recognition and liability reserves [1][2]. Group 1: Allegations and Lawsuit Details - Hagens Berman is investigating claims that Ardent misled investors about its revenue recognition systems and the adequacy of its professional liability reserves [2]. - The lawsuit claims that Ardent assured investors of an active monitoring process for accounts receivable, which was misleading as the company primarily used a 180-day cliff for reserving accounts [4][6]. - The truth emerged on November 12, 2025, when Ardent disclosed a new accounting method that resulted in a revenue reduction of $42.6 million due to hindsight evaluations [5][6]. Group 2: Financial Impact and Market Reaction - Following the earnings call, Ardent's CFO revealed that the company's collectability framework utilized a 180-day cliff for reserving accounts, contradicting previous assurances [6]. - The company also reported an increase in total operating expenses as a percentage of total revenue, driven by a $47.2 million increase in professional liability reserves [6]. - The market reacted negatively, with Ardent's share price dropping by $4.75, or 33%, the day after the announcement [6]. Group 3: Investor Actions and Whistleblower Information - Investors who purchased Ardent securities between July 18, 2024, and November 12, 2025, and suffered losses are encouraged to contact Hagens Berman [2][4]. - Whistleblowers with non-public information regarding Ardent Health are urged to consider their options to assist in the investigation, with potential rewards under the SEC Whistleblower program [7].

Core Viewpoint - Hagens Berman is notifying investors about a securities class action against Klarna Group plc, focusing on alleged misstatements in the company's September 2025 IPO documents, with a lead plaintiff deadline set for February 20, 2026 [1][2]. Summary by Relevant Sections Class Action Details - The class action involves investors who purchased shares during Klarna's September 2025 IPO and experienced significant losses [2]. - The core allegation is that Klarna's IPO documents understated credit loss reserves and risks associated with "Fair Financing" [2]. Allegations Against Klarna - The lawsuit claims that Klarna's IPO Registration Statement and Prospectus contained misleading statements regarding credit modeling and risk management [3]. - Specifically, it is alleged that the offering documents materially understated the credit risks of lending to financially unsophisticated clients and those in financial hardship, which led to an underestimation of potential increases in loss provisions [4]. Financial Performance and Impact - On November 18, 2025, Klarna reported a 102% year-over-year increase in its provision for credit losses and a significant rise in operating losses, resulting in the stock price dropping nearly 22% below its IPO price [5]. - The investigation is focused on whether the IPO documents adequately disclosed the company's credit risks, especially given the doubling of credit loss provisions shortly after the IPO [6]. Legal Process and Contact Information - The deadline for appointing a lead plaintiff in the class action is February 20, 2026, with the lead plaintiff representing other class members in the litigation [7]. - Investors can contact Hagens Berman to report losses or seek more information about the case through their secure portal or email [8].

Core Points - A securities class action lawsuit has been filed against CoreWeave, Inc. and certain executives, representing investors who acquired CoreWeave securities between March 28, 2025, and December 15, 2025 [1] - The lawsuit is a response to delays from a third-party data center developer, which has negatively impacted CoreWeave's share price [2] - Hagens Berman, a national shareholder rights firm, is investigating claims that CoreWeave misled investors, urging those who suffered losses to come forward [3] Company Performance and Allegations - The complaint centers on CoreWeave's statements regarding its ability to meet high demand for its services and recognize revenue from long-term contracts [4] - Allegations include that CoreWeave overstated its capacity to meet customer demand and downplayed risks associated with reliance on a single third-party data center supplier [5] - Following a disappointing Q3 2025 financial report and a reduction in revenue guidance, CoreWeave's share price fell by $36.11, a decrease of 34%, resulting in a loss of approximately $14 billion in market capitalization [6] Investigation and Whistleblower Information - Hagens Berman is investigating whether CoreWeave intentionally misled investors about its business prospects [7] - The firm encourages individuals with non-public information regarding CoreWeave to consider participating in the investigation or the SEC Whistleblower program [7]

Core Viewpoint - Hagens Berman is notifying investors about a securities class action against Fermi Inc. regarding misleading information related to tenant demand and funding for its "Project Matador" AI campus [1][4]. Summary by Relevant Sections Class Action Details - The lead plaintiff deadline for the Fermi class action is set for March 6, 2026 [3][8]. - The class period for the lawsuit covers purchases made from October 1, 2025, to December 11, 2025 [3][8]. - The core allegation involves overstated tenant demand and undisclosed risks associated with the primary anchor tenant [3][7]. Stock Price Impact - Following the termination of the $150 million Advance in Aid of Construction Agreement by the First Tenant, Fermi's stock price dropped by 33.8% in a single day, closing at $10.09 per share, which is over 50% below its IPO price of $21.00 [5][8]. Project Matador Overview - Fermi's "Project Matador" is described as a multi-gigawatt energy and data center development aimed at supporting AI needs [4]. - The company had previously highlighted an agreement with an investment-grade tenant, which was a significant part of its IPO materials [4]. Investigation Insights - Hagens Berman is investigating whether Fermi's management was transparent about the status of Project Matador [6].

Core观点 - A securities class-action lawsuit has been filed against CoreWeave, Inc. and several executives, alleging misleading statements regarding delays in its Denton, Texas data center cluster [1] 分组1 - The lawsuit is on behalf of investors who purchased CoreWeave securities between March 28 and December 15, 2025 [1] - The allegations focus on misrepresentation related to the data center intended to support OpenAI operations [1] - Hagens Berman is currently reviewing CoreWeave's statements regarding its operations [1]

Core Viewpoint - A securities class action lawsuit has been filed against CoreWeave, Inc. and certain executives, representing investors who acquired CoreWeave securities between March 28, 2025, and December 15, 2025 [1] Group 1: Lawsuit Details - The lawsuit follows revelations about delays from a third-party data center developer, impacting CoreWeave's Denton, Texas data center cluster intended for OpenAI, which has led to a significant decline in share price [2] - Hagens Berman, a national shareholder rights firm, is investigating claims that CoreWeave misled investors, urging those who suffered losses to come forward [3] - The complaint focuses on CoreWeave's statements regarding its ability to meet high demand for services and recognize revenue from long-term contracts with customers [4] Group 2: Allegations of Misleading Information - The lawsuit alleges that CoreWeave made misleading statements and failed to disclose its overstated ability to meet customer demand [5] - CoreWeave is accused of underestimating the risks associated with its reliance on a single third-party data center supplier, affecting its ability to meet customer demand and recognize revenue [5] Group 3: Market Reaction and Financial Impact - Investors began questioning CoreWeave's transparency after the company reported Q3 2025 financial results on November 10, 2025, which included a surprising reduction in full-year revenue guidance due to delays from a third-party developer [6] - Following a report from The Wall Street Journal on December 15, 2025, regarding ongoing delays from the data center supplier, CoreWeave's share price dropped by $36.11, a decline of 34%, resulting in a loss of approximately $14 billion in market capitalization within a month [6]

Core Viewpoint - Hagens Berman is investigating Alvotech regarding its disclosures related to manufacturing operations and the regulatory status of its lead biosimilar candidate, AVT05, following a significant stock drop of 34% after receiving a Complete Response Letter from the FDA [1] Company Summary - Alvotech's stock experienced a 34% decline after the announcement of receiving a Complete Response Letter (CRL) from the FDA [1] - The investigation by Hagens Berman focuses on the propriety of Alvotech's disclosures concerning its manufacturing operations [1] - The regulatory status of Alvotech's lead biosimilar candidate, AVT05, is under scrutiny as part of the investigation [1]

Core Viewpoint - A class-action lawsuit has been filed against Starbucks Corporation, alleging that the company misleads consumers by claiming to be "Committed to 100% Ethical Coffee Sourcing" while concealing systematic human rights and labor law violations in its supply chain [1][2]. Human Rights Violations - The lawsuit accuses Starbucks of making false representations regarding its ethical sourcing practices, particularly through its C.A.F.E. (Coffee And Farmer Equity) Practices program, which is claimed to be misleading due to documented inaction on human rights violations [4]. - Investigations have revealed extensive human rights abuses, including degrading working conditions and inadequate housing for workers on farms certified under Starbucks' program [5][6]. - A specific complaint from the Brazilian government in 2022 highlighted abusive conditions at Cooxupé, Starbucks' largest supplier in Brazil, which accounts for 40% of its Brazilian coffee supply [6]. Safety: Decaffeination and Chemicals - The lawsuit also addresses misrepresentation regarding Starbucks' decaffeinated coffee, claiming that it contains detectable levels of industrial solvents and volatile organic compounds (VOCs) that are not disclosed to consumers [7]. - Independent testing revealed the presence of harmful substances such as methylene chloride, benzene, and toluene in Starbucks' decaf coffee products, which could be material to consumers concerned about health and safety [8].

Core Viewpoint - Hagens Berman is notifying investors about a pending securities class action against StubHub Holdings, Inc. regarding undisclosed adverse trends in vendor payments that led to a significant decline in free cash flow following its September 2025 IPO [1][4]. Group 1: Legal Proceedings - The lead plaintiff deadline for the class action is set for January 23, 2026, targeting investors who purchased StubHub securities during the September 2025 IPO [3][8]. - The core allegation of the lawsuit is that StubHub failed to disclose critical changes in vendor payment timing that adversely affected its liquidity [3][7]. Group 2: Financial Impact - StubHub reported a free cash flow decline of 143%, resulting in negative $4.6 million for the quarter following its IPO, attributed to changes in vendor payment timing [5][6]. - Following the disclosure of this financial downturn, StubHub's stock price fell over 20% in one day and has traded as much as 56% below its IPO price of $23.50 [5]. Group 3: Company Background - Hagens Berman is a global plaintiffs' rights complex litigation firm that focuses on corporate accountability and has secured over $2.9 billion for clients in similar cases [9][10].